Endomorphin-1 vs Endomorphin-2 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Endomorphin-1 (Tyr-Pro-Trp-Phe-NH2) is a tetrapeptide amide isolated from bovine frontal cortex and proposed as an endogenous mu opioid receptor (MOR) ligand with the highest known selectivity for MOR among any endogenous opioid peptide. Unlike enkephalins and endorphins that act...
Calculate Endomorphin-1 dose →Endomorphin-2 (Tyr-Pro-Phe-Phe-NH2) is the second member of the endomorphin family, differing from endomorphin-1 by a single residue (Phe for Trp at position 3). Both share extraordinary MOR selectivity (>4000-fold over delta and kappa opioid receptors), but their neuroanatomical...
Calculate Endomorphin-2 dose →| Parameter | Endomorphin-1 | Endomorphin-2 |
|---|---|---|
| Category | Endogenous Opioid / Mu Selective | Endogenous Opioid / Mu Selective |
| Research | Research / Endogenous Peptide | Research / Endogenous Peptide |
| Half-Life | 1-5 minutes (plasma; rapid enzymatic degradation) | 1-5 minutes (plasma) |
| Typical Dose | Research: 1-10 nmol intrathecal; 10-100 nmol ICV (rodent) | Research: 1-10 nmol intrathecal; 10-100 nmol ICV (rodent) |
| Frequency | Endogenous: activity-dependent; research per session | Per research session |
| Route | Endogenous (CNS); research intrathecal/ICV/SC | Endogenous (spinal cord, brainstem); research intrathecal/ICV |
| FDA Status | Not approved; research peptide | Not approved; research peptide |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.